BioStem BSEM Stock
BioStem Price Chart
BioStem BSEM Financial and Trading Overview
| BioStem stock price | 14.69 USD |
| Previous Close | 1.99 USD |
| Open | 2 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 2 - 2 USD |
| 52 Week Range | 1.3 - 4.34 USD |
| Volume | 1.39K USD |
| Avg. Volume | 969 USD |
| Market Cap | 26.2M USD |
| Beta (5Y Monthly) | 1.510563 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.57 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.35 USD |
BSEM Valuation Measures
| Enterprise Value | 28.23M USD |
| Trailing P/E | N/A |
| Forward P/E | -33.333336 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 122.97907 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 132.497 |
| Enterprise Value/EBITDA | -7.577 |
Trading Information
BioStem Stock Price History
| Beta (5Y Monthly) | 1.510563 |
| 52-Week Change | 2.04% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.34 USD |
| 52 Week Low | 1.3 USD |
| 50-Day Moving Average | 2.12 USD |
| 200-Day Moving Average | 2.96 USD |
BSEM Share Statistics
| Avg. Volume (3 month) | 969 USD |
| Avg. Daily Volume (10-Days) | 930 USD |
| Shares Outstanding | 13.1M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2017 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2018 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1822.25% |
| Gross Margin | 51.62% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -60.17% |
| Return on Equity (ttm) | -221.015% |
Income Statement
| Revenue (ttm) | 213.05K USD |
| Revenue Per Share (ttm) | 0.03 USD |
| Quarterly Revenue Growth (yoy) | -12.69% |
| Gross Profit (ttm) | 163.78K USD |
| EBITDA | -3725487 USD |
| Net Income Avi to Common (ttm) | -4172920 USD |
| Diluted EPS (ttm) | -0.46 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.04M USD |
| Total Cash Per Share (mrq) | 0.09 USD |
| Total Debt (mrq) | 4.85M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.261 |
| Book Value Per Share (mrq) | -0.263 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1859935 USD |
| Levered Free Cash Flow (ttm) | 2.43M USD |
Profile of BioStem
| Country | United States |
| State | FL |
| City | Pompano Beach |
| Address | 2836 Center Port Circle |
| ZIP | 33064 |
| Phone | 954 380 8342 |
| Website | https://www.biostemtechnologies.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
Q&A For BioStem Stock
What is a current BSEM stock price?
BioStem BSEM stock price today per share is 14.69 USD.
How to purchase BioStem stock?
You can buy BSEM shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioStem?
The stock symbol or ticker of BioStem is BSEM.
Which industry does the BioStem company belong to?
The BioStem industry is Biotechnology.
How many shares does BioStem have in circulation?
The max supply of BioStem shares is 16.64M.
What is BioStem Price to Earnings Ratio (PE Ratio)?
BioStem PE Ratio is now.
What was BioStem earnings per share over the trailing 12 months (TTM)?
BioStem EPS is -0.57 USD over the trailing 12 months.
Which sector does the BioStem company belong to?
The BioStem sector is Healthcare.